RecruitingPhase 4NCT06233604
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty
Sponsor
Poznan University of Medical Sciences
Enrollment
30 participants
Start Date
Apr 10, 2024
Study Type
INTERVENTIONAL
Summary
Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for hip arthroplasty
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria3
- patients undergoing primary hip arthroplasty
- aged >18 years and <100 years
- ASA physical status 1, 2 or 3.
Exclusion Criteria12
- if they refused to participate,
- had a history of opioid abuse,
- had an infection of the site of needle puncture,
- were less than 18 years of age,
- were postponed as having ASA 4 or 5,
- had an allergy to any of the drugs used in the study,
- renal failure (estimated glomerular filtration rate <15ml/min/1.73m2),
- liver failure,
- known or suspected coagulopathy,
- pre-existing anatomical or neurological disorders in the lower extremities,
- intellectual disability with problems in pain evaluation,
- severe psychiatric illness.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUG0.9%sodium chloride
unilateral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block
DRUGDexamethasone
unilateral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block
DRUGDexmedetomidine
unilateral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06233604